ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic Antibodies Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-4Z16321
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Therapeutic Antibodies Drug Market Research Report 2023
BUY CHAPTERS

Global Therapeutic Antibodies Drug Market Research Report 2025

Code: QYRE-Auto-4Z16321
Report
May 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol–Myers Squibb
Amgen Inc
Astrazeneca plc
Merck
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer Inc
Regeneron
Innovent
Hengrui Medicine

Therapeutic Antibodies Drug Market Size

The global market for Therapeutic Antibodies Drug was valued at US$ 213980 million in the year 2024 and is projected to reach a revised size of US$ 439860 million by 2031, growing at a CAGR of 11.0% during the forecast period.

Therapeutic Antibodies Drug Market

Therapeutic Antibodies Drug Market

Therapeutic antibodies are drugs that use antibodies, one of the main players in our immune system inherent in our body. By making use of the specificity by which each antibody recognizes only one antigen, pinpointed attacks on specific antigens are possible.
The Therapeutic Antibodies Drug Market is driven by the remarkable potential of therapeutic antibodies to treat a diverse array of diseases, from cancer and autoimmune disorders to infectious diseases. Monoclonal antibodies have gained prominence as highly targeted and effective therapeutic agents that can modulate the immune system, neutralize pathogens, and inhibit disease-associated proteins. As precision medicine and biopharmaceutical innovations continue to advance, the demand for therapeutic antibodies grows. Innovations in antibody design, engineering, and manufacturing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to address high production costs, optimize therapeutic antibody development processes, and navigate complex regulatory pathways while ensuring accessibility and affordability for patients. Overcoming manufacturing complexities, managing research and development costs, and addressing regulatory standards are ongoing challenges. Additionally, the market faces competition from small molecules and other biologic therapies, necessitating continuous research and development efforts to unlock the full therapeutic potential of therapeutic antibodies. Striking a balance between providing safe, effective, and accessible therapeutic antibody drugs while addressing scientific and regulatory challenges is essential for the continued growth of the Therapeutic Antibodies Drug Market.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Antibodies Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Antibodies Drug.
The Therapeutic Antibodies Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Antibodies Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Antibodies Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Therapeutic Antibodies Drug Market Report

Report Metric Details
Report Name Therapeutic Antibodies Drug Market
Accounted market size in year US$ 213980 million
Forecasted market size in 2031 US$ 439860 million
CAGR 11.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Monoclonal Antibodies
  • Bi-Specific Antibodies Therapy
  • Antibody-drug Conjugates
  • Other
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, Regeneron, Innovent, Hengrui Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Therapeutic Antibodies Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Therapeutic Antibodies Drug Market growing?

Ans: The Therapeutic Antibodies Drug Market witnessing a CAGR of 11.0% during the forecast period 2025-2031.

What is the Therapeutic Antibodies Drug Market size in 2031?

Ans: The Therapeutic Antibodies Drug Market size in 2031 will be US$ 439860 million.

Who are the main players in the Therapeutic Antibodies Drug Market report?

Ans: The main players in the Therapeutic Antibodies Drug Market are AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, Regeneron, Innovent, Hengrui Medicine

What are the Application segmentation covered in the Therapeutic Antibodies Drug Market report?

Ans: The Applications covered in the Therapeutic Antibodies Drug Market report are Immune Diseases, Cancer, Other

What are the Type segmentation covered in the Therapeutic Antibodies Drug Market report?

Ans: The Types covered in the Therapeutic Antibodies Drug Market report are Monoclonal Antibodies, Bi-Specific Antibodies Therapy, Antibody-drug Conjugates, Other

Recommended Reports

Antibody Therapeutics

Immunology Diseases

Oncology Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Antibodies Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Bi-Specific Antibodies Therapy
1.2.4 Antibody-drug Conjugates
1.2.5 Other
1.3 Market by Application
1.3.1 Global Therapeutic Antibodies Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immune Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Antibodies Drug Market Perspective (2020-2031)
2.2 Global Therapeutic Antibodies Drug Growth Trends by Region
2.2.1 Global Therapeutic Antibodies Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Therapeutic Antibodies Drug Historic Market Size by Region (2020-2025)
2.2.3 Therapeutic Antibodies Drug Forecasted Market Size by Region (2026-2031)
2.3 Therapeutic Antibodies Drug Market Dynamics
2.3.1 Therapeutic Antibodies Drug Industry Trends
2.3.2 Therapeutic Antibodies Drug Market Drivers
2.3.3 Therapeutic Antibodies Drug Market Challenges
2.3.4 Therapeutic Antibodies Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Antibodies Drug Players by Revenue
3.1.1 Global Top Therapeutic Antibodies Drug Players by Revenue (2020-2025)
3.1.2 Global Therapeutic Antibodies Drug Revenue Market Share by Players (2020-2025)
3.2 Global Therapeutic Antibodies Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Therapeutic Antibodies Drug Revenue
3.4 Global Therapeutic Antibodies Drug Market Concentration Ratio
3.4.1 Global Therapeutic Antibodies Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Antibodies Drug Revenue in 2024
3.5 Global Key Players of Therapeutic Antibodies Drug Head office and Area Served
3.6 Global Key Players of Therapeutic Antibodies Drug, Product and Application
3.7 Global Key Players of Therapeutic Antibodies Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Antibodies Drug Breakdown Data by Type
4.1 Global Therapeutic Antibodies Drug Historic Market Size by Type (2020-2025)
4.2 Global Therapeutic Antibodies Drug Forecasted Market Size by Type (2026-2031)
5 Therapeutic Antibodies Drug Breakdown Data by Application
5.1 Global Therapeutic Antibodies Drug Historic Market Size by Application (2020-2025)
5.2 Global Therapeutic Antibodies Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Therapeutic Antibodies Drug Market Size (2020-2031)
6.2 North America Therapeutic Antibodies Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Therapeutic Antibodies Drug Market Size by Country (2020-2025)
6.4 North America Therapeutic Antibodies Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Antibodies Drug Market Size (2020-2031)
7.2 Europe Therapeutic Antibodies Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Therapeutic Antibodies Drug Market Size by Country (2020-2025)
7.4 Europe Therapeutic Antibodies Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Antibodies Drug Market Size (2020-2031)
8.2 Asia-Pacific Therapeutic Antibodies Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Therapeutic Antibodies Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Therapeutic Antibodies Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Antibodies Drug Market Size (2020-2031)
9.2 Latin America Therapeutic Antibodies Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Therapeutic Antibodies Drug Market Size by Country (2020-2025)
9.4 Latin America Therapeutic Antibodies Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Antibodies Drug Market Size (2020-2031)
10.2 Middle East & Africa Therapeutic Antibodies Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Therapeutic Antibodies Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Therapeutic Antibodies Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Therapeutic Antibodies Drug Introduction
11.1.4 AbbVie Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Therapeutic Antibodies Drug Introduction
11.2.4 Johnson & Johnson Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Therapeutic Antibodies Drug Introduction
11.3.4 Novartis Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Details
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Therapeutic Antibodies Drug Introduction
11.4.4 Gilead Sciences Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.4.5 Gilead Sciences Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Therapeutic Antibodies Drug Introduction
11.5.4 Roche Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Therapeutic Antibodies Drug Introduction
11.6.4 Bristol-Myers Squibb Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Therapeutic Antibodies Drug Introduction
11.7.4 Amgen Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.7.5 Amgen Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Therapeutic Antibodies Drug Introduction
11.8.4 AstraZeneca Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.8.5 AstraZeneca Recent Development
11.9 Merck & Co
11.9.1 Merck & Co Company Details
11.9.2 Merck & Co Business Overview
11.9.3 Merck & Co Therapeutic Antibodies Drug Introduction
11.9.4 Merck & Co Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.9.5 Merck & Co Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Therapeutic Antibodies Drug Introduction
11.10.4 Takeda Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.10.5 Takeda Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Therapeutic Antibodies Drug Introduction
11.11.4 Merck KGaA Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.11.5 Merck KGaA Recent Development
11.12 Seagen
11.12.1 Seagen Company Details
11.12.2 Seagen Business Overview
11.12.3 Seagen Therapeutic Antibodies Drug Introduction
11.12.4 Seagen Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.12.5 Seagen Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Therapeutic Antibodies Drug Introduction
11.13.4 Eli Lilly Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.13.5 Eli Lilly Recent Development
11.14 Ono Pharmaceutical
11.14.1 Ono Pharmaceutical Company Details
11.14.2 Ono Pharmaceutical Business Overview
11.14.3 Ono Pharmaceutical Therapeutic Antibodies Drug Introduction
11.14.4 Ono Pharmaceutical Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.14.5 Ono Pharmaceutical Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Therapeutic Antibodies Drug Introduction
11.15.4 Pfizer Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.15.5 Pfizer Recent Development
11.16 Regeneron
11.16.1 Regeneron Company Details
11.16.2 Regeneron Business Overview
11.16.3 Regeneron Therapeutic Antibodies Drug Introduction
11.16.4 Regeneron Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.16.5 Regeneron Recent Development
11.17 Innovent
11.17.1 Innovent Company Details
11.17.2 Innovent Business Overview
11.17.3 Innovent Therapeutic Antibodies Drug Introduction
11.17.4 Innovent Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.17.5 Innovent Recent Development
11.18 Hengrui Medicine
11.18.1 Hengrui Medicine Company Details
11.18.2 Hengrui Medicine Business Overview
11.18.3 Hengrui Medicine Therapeutic Antibodies Drug Introduction
11.18.4 Hengrui Medicine Revenue in Therapeutic Antibodies Drug Business (2020-2025)
11.18.5 Hengrui Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol–Myers Squibb
Amgen Inc
Astrazeneca plc
Merck
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer Inc
Regeneron
Innovent
Hengrui Medicine
List of Tables
 Table 1. Global Therapeutic Antibodies Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibodies
 Table 3. Key Players of Bi-Specific Antibodies Therapy
 Table 4. Key Players of Antibody-drug Conjugates
 Table 5. Key Players of Other
 Table 6. Global Therapeutic Antibodies Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Therapeutic Antibodies Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Therapeutic Antibodies Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Therapeutic Antibodies Drug Market Share by Region (2020-2025)
 Table 10. Global Therapeutic Antibodies Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Therapeutic Antibodies Drug Market Share by Region (2026-2031)
 Table 12. Therapeutic Antibodies Drug Market Trends
 Table 13. Therapeutic Antibodies Drug Market Drivers
 Table 14. Therapeutic Antibodies Drug Market Challenges
 Table 15. Therapeutic Antibodies Drug Market Restraints
 Table 16. Global Therapeutic Antibodies Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Therapeutic Antibodies Drug Market Share by Players (2020-2025)
 Table 18. Global Top Therapeutic Antibodies Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Antibodies Drug as of 2024)
 Table 19. Ranking of Global Top Therapeutic Antibodies Drug Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Therapeutic Antibodies Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Therapeutic Antibodies Drug, Headquarters and Area Served
 Table 22. Global Key Players of Therapeutic Antibodies Drug, Product and Application
 Table 23. Global Key Players of Therapeutic Antibodies Drug, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Therapeutic Antibodies Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Therapeutic Antibodies Drug Revenue Market Share by Type (2020-2025)
 Table 27. Global Therapeutic Antibodies Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Therapeutic Antibodies Drug Revenue Market Share by Type (2026-2031)
 Table 29. Global Therapeutic Antibodies Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Therapeutic Antibodies Drug Revenue Market Share by Application (2020-2025)
 Table 31. Global Therapeutic Antibodies Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Therapeutic Antibodies Drug Revenue Market Share by Application (2026-2031)
 Table 33. North America Therapeutic Antibodies Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Therapeutic Antibodies Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Therapeutic Antibodies Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Therapeutic Antibodies Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Therapeutic Antibodies Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Therapeutic Antibodies Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Therapeutic Antibodies Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Therapeutic Antibodies Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Therapeutic Antibodies Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Therapeutic Antibodies Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Therapeutic Antibodies Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Therapeutic Antibodies Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Therapeutic Antibodies Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Therapeutic Antibodies Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Therapeutic Antibodies Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 48. AbbVie Company Details
 Table 49. AbbVie Business Overview
 Table 50. AbbVie Therapeutic Antibodies Drug Product
 Table 51. AbbVie Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 52. AbbVie Recent Development
 Table 53. Johnson & Johnson Company Details
 Table 54. Johnson & Johnson Business Overview
 Table 55. Johnson & Johnson Therapeutic Antibodies Drug Product
 Table 56. Johnson & Johnson Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 57. Johnson & Johnson Recent Development
 Table 58. Novartis Company Details
 Table 59. Novartis Business Overview
 Table 60. Novartis Therapeutic Antibodies Drug Product
 Table 61. Novartis Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 62. Novartis Recent Development
 Table 63. Gilead Sciences Company Details
 Table 64. Gilead Sciences Business Overview
 Table 65. Gilead Sciences Therapeutic Antibodies Drug Product
 Table 66. Gilead Sciences Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 67. Gilead Sciences Recent Development
 Table 68. Roche Company Details
 Table 69. Roche Business Overview
 Table 70. Roche Therapeutic Antibodies Drug Product
 Table 71. Roche Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 72. Roche Recent Development
 Table 73. Bristol-Myers Squibb Company Details
 Table 74. Bristol-Myers Squibb Business Overview
 Table 75. Bristol-Myers Squibb Therapeutic Antibodies Drug Product
 Table 76. Bristol-Myers Squibb Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 77. Bristol-Myers Squibb Recent Development
 Table 78. Amgen Company Details
 Table 79. Amgen Business Overview
 Table 80. Amgen Therapeutic Antibodies Drug Product
 Table 81. Amgen Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 82. Amgen Recent Development
 Table 83. AstraZeneca Company Details
 Table 84. AstraZeneca Business Overview
 Table 85. AstraZeneca Therapeutic Antibodies Drug Product
 Table 86. AstraZeneca Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 87. AstraZeneca Recent Development
 Table 88. Merck & Co Company Details
 Table 89. Merck & Co Business Overview
 Table 90. Merck & Co Therapeutic Antibodies Drug Product
 Table 91. Merck & Co Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 92. Merck & Co Recent Development
 Table 93. Takeda Company Details
 Table 94. Takeda Business Overview
 Table 95. Takeda Therapeutic Antibodies Drug Product
 Table 96. Takeda Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 97. Takeda Recent Development
 Table 98. Merck KGaA Company Details
 Table 99. Merck KGaA Business Overview
 Table 100. Merck KGaA Therapeutic Antibodies Drug Product
 Table 101. Merck KGaA Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 102. Merck KGaA Recent Development
 Table 103. Seagen Company Details
 Table 104. Seagen Business Overview
 Table 105. Seagen Therapeutic Antibodies Drug Product
 Table 106. Seagen Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 107. Seagen Recent Development
 Table 108. Eli Lilly Company Details
 Table 109. Eli Lilly Business Overview
 Table 110. Eli Lilly Therapeutic Antibodies Drug Product
 Table 111. Eli Lilly Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 112. Eli Lilly Recent Development
 Table 113. Ono Pharmaceutical Company Details
 Table 114. Ono Pharmaceutical Business Overview
 Table 115. Ono Pharmaceutical Therapeutic Antibodies Drug Product
 Table 116. Ono Pharmaceutical Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 117. Ono Pharmaceutical Recent Development
 Table 118. Pfizer Company Details
 Table 119. Pfizer Business Overview
 Table 120. Pfizer Therapeutic Antibodies Drug Product
 Table 121. Pfizer Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 122. Pfizer Recent Development
 Table 123. Regeneron Company Details
 Table 124. Regeneron Business Overview
 Table 125. Regeneron Therapeutic Antibodies Drug Product
 Table 126. Regeneron Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 127. Regeneron Recent Development
 Table 128. Innovent Company Details
 Table 129. Innovent Business Overview
 Table 130. Innovent Therapeutic Antibodies Drug Product
 Table 131. Innovent Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 132. Innovent Recent Development
 Table 133. Hengrui Medicine Company Details
 Table 134. Hengrui Medicine Business Overview
 Table 135. Hengrui Medicine Therapeutic Antibodies Drug Product
 Table 136. Hengrui Medicine Revenue in Therapeutic Antibodies Drug Business (2020-2025) & (US$ Million)
 Table 137. Hengrui Medicine Recent Development
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Therapeutic Antibodies Drug Picture
 Figure 2. Global Therapeutic Antibodies Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Therapeutic Antibodies Drug Market Share by Type: 2024 VS 2031
 Figure 4. Monoclonal Antibodies Features
 Figure 5. Bi-Specific Antibodies Therapy Features
 Figure 6. Antibody-drug Conjugates Features
 Figure 7. Other Features
 Figure 8. Global Therapeutic Antibodies Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Therapeutic Antibodies Drug Market Share by Application: 2024 VS 2031
 Figure 10. Immune Diseases Case Studies
 Figure 11. Cancer Case Studies
 Figure 12. Other Case Studies
 Figure 13. Therapeutic Antibodies Drug Report Years Considered
 Figure 14. Global Therapeutic Antibodies Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Therapeutic Antibodies Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Therapeutic Antibodies Drug Market Share by Region: 2024 VS 2031
 Figure 17. Global Therapeutic Antibodies Drug Market Share by Players in 2024
 Figure 18. Global Top Therapeutic Antibodies Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Antibodies Drug as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Therapeutic Antibodies Drug Revenue in 2024
 Figure 20. North America Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Therapeutic Antibodies Drug Market Share by Country (2020-2031)
 Figure 22. United States Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Therapeutic Antibodies Drug Market Share by Country (2020-2031)
 Figure 26. Germany Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Therapeutic Antibodies Drug Market Share by Region (2020-2031)
 Figure 34. China Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Therapeutic Antibodies Drug Market Share by Country (2020-2031)
 Figure 42. Mexico Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Therapeutic Antibodies Drug Market Share by Country (2020-2031)
 Figure 46. Turkey Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Therapeutic Antibodies Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. AbbVie Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 50. Johnson & Johnson Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 51. Novartis Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 52. Gilead Sciences Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 53. Roche Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 55. Amgen Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 56. AstraZeneca Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 57. Merck & Co Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 58. Takeda Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 59. Merck KGaA Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 60. Seagen Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 61. Eli Lilly Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 62. Ono Pharmaceutical Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 63. Pfizer Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 64. Regeneron Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 65. Innovent Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 66. Hengrui Medicine Revenue Growth Rate in Therapeutic Antibodies Drug Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Antibody Based Therapeutics Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global Research Area Antibodies Market Research Report 2025
Therapeutic Antibody Discovery Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Antibody Market Research Report 2025
Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024
Global Bcl 2 Antibody Market Research Report 2024
Antibody Therapeutics and Blood Antibody Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Protein Drug Market Research Report 2024
Global Immune Cell Therapy Drugs Market Research Report 2025
Global GFP Antibody Market Research Report 2024
Global BAG1 Antibody Market Research Report 2024
Global Biosimilar Antibodies Market Research Report 2024
Global F11R Antibody Market Research Report 2024
Global Next Generation Antibody Drug Market Research Report 2024
Global Immunoglobulin G Antibody Therapeutics Market Insights Forecast to 2030
Global Small Molecule Targeted Cancer Therapy Market Research Report 2025
Global C Kit Antibody Market Research Report 2024
Global Vectorized Antibodies Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions